Skip to content
Back to Guavy Wire
Stocks

CVS Health Q2 Earnings: Flat Revenue Growth Ahead

Instruments
UNH
Share

CVS Health (NYSE: CVS) is set to release its Q2 earnings report on Wednesday before the bell. The diversified healthcare company beat analysts' revenue expectations last quarter, reporting revenues of $100.4 billion, up 6.2% year on year.

This time around, market expectations are for flat year-on-year revenue growth, a slowdown from the 8.4% increase in Q2 last year. Analysts covering CVS Health have reconfirmed their estimates over the last 30 days, indicating they anticipate the company will maintain its pace.

CVS Health rarely misses Wall Street's revenue estimates. A look at its peers in the health insurance providers segment shows that some have already reported their Q2 results. Centene delivered year-on-year revenue growth of 9.9%, beating analysts' expectations by 13.1%. UnitedHealth reported flat revenue, topping estimates by 1.2%.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc